These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 7867381)

  • 21. Systemic involvement in TREX1-associated familial chilblain lupus.
    Günther C; Hillebrand M; Brunk J; Lee-Kirsch MA
    J Am Acad Dermatol; 2013 Oct; 69(4):e179-81. PubMed ID: 24034389
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative Analysis of Chilblain Lupus Erythematosus and Idiopathic Perniosis: Histopathologic Features and Immunohistochemistry for CD123 and CD30.
    Wang ML; Chan MP
    Am J Dermatopathol; 2018 Apr; 40(4):265-271. PubMed ID: 28719438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study.
    Francès C; Cosnes A; Duhaut P; Zahr N; Soutou B; Ingen-Housz-Oro S; Bessis D; Chevrant-Breton J; Cordel N; Lipsker D; Costedoat-Chalumeau N
    Arch Dermatol; 2012 Apr; 148(4):479-84. PubMed ID: 22508872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic features of cutaneous lupus erythematosus.
    Baltaci M; Fritsch P
    Autoimmun Rev; 2009 May; 8(6):467-73. PubMed ID: 19162243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tender macules and papules on the toes.
    Mireku KA; Glover MH; Davis L
    JAMA Dermatol; 2014 Mar; 150(3):329-30. PubMed ID: 24429477
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of lenalidomide in refractory lupus pernio.
    Dalm VA; van Hagen PM
    JAMA Dermatol; 2013 Apr; 149(4):493-4. PubMed ID: 23715134
    [No Abstract]   [Full Text] [Related]  

  • 27. Tofacitinib for refractory chilblain lupus erythematosus.
    Elman SA; Mazori DR; Merola JF
    Int J Dermatol; 2022 Apr; 61(4):e156-e157. PubMed ID: 34075576
    [No Abstract]   [Full Text] [Related]  

  • 28. Chilblain lupus during treatment with golimumab for rheumatoid arthritis.
    Urata Y; Honda T; Kaku Y; Kabashima K
    J Dermatol; 2019 Sep; 46(9):e314-e315. PubMed ID: 30951207
    [No Abstract]   [Full Text] [Related]  

  • 29. Chilblain Lupus Erythematosus.
    Wang WY; Lin MC
    N Engl J Med; 2024 Jul; 391(4):e6. PubMed ID: 39047243
    [No Abstract]   [Full Text] [Related]  

  • 30. [Three cases of bullous lupus erythematosus].
    Jira M; Elqatni M; Sekkach Y; Elomri N; Mekouar F; Ghafir D
    Ann Dermatol Venereol; 2013 Dec; 140(12):778-83. PubMed ID: 24315223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aicardi-Goutières syndrome: cold-induced acral blemish is not always cryoglobulinaemic vasculitis or chilblain lupus.
    Singh S; Taneja N; Bala P; Verma KK; Devarajan LSJ
    Clin Exp Dermatol; 2018 Jun; 43(4):488-490. PubMed ID: 29341198
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
    Günther C; Meurer M; Stein A; Viehweg A; Lee-Kirsch MA
    Dermatology; 2009; 219(2):162-6. PubMed ID: 19478477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chilblain lupus erythematosus presenting with bilateral hemorrhagic bullae of distal halluces.
    Aleshin M; Martin S; Palla B; Holland V; Young L
    Cutis; 2018 Jun; 101(6):E16-E18. PubMed ID: 30063789
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review.
    Vieira ML; Marques ERMC; Leda YLA; Noriega LF; Bet DL; Pereira GAAM
    Lupus; 2018 Apr; 27(5):853-857. PubMed ID: 28857716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An erythematous plaque on the nose.
    Arias-Santiago S; Soriano-Hernández MI; Aneiros-Fernández J; Burkhardt-Pérez P; Buendía-Eisman A; Naranjo-Sintes R; Alaminos-Mingorance M
    Cleve Clin J Med; 2011 Nov; 78(11):728-32. PubMed ID: 22049539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.